Clinical trial
A Pilot Study of Etanercept in Dermatomyositis
NCT00112385 · Brigham and Women's Hospital, Other · Completed
Key facts
| NCT number | NCT00112385 |
|---|---|
| Title | A Pilot Study of Etanercept in Dermatomyositis |
| Official title | A Pilot Study of Etanercept in Dermatomyositis |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Collaborators | Amgen Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Dermatomyositis |
| Intervention type | Drug |
| Interventions | Etanercept, Placebo |
| Enrollment | 16 |
| Start date | Mar 1, 2006 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Jun 3, 2005 |
| Last update posted | Jun 21, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: